CMF
ADPT icon

Counterpoint Mutual Funds’s Adaptive Biotechnologies ADPT Stock Holding History

Counterpoint Mutual Funds’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-307,268
Closed -$4.26M – 300
2026
Q1 		$4.26M Buy
+307,268
New +$4.9M 0.64% 38
2025
Q4 		– Sell
-37,214
Closed -$557K – 346
2025
Q3 		$557K Buy
+37,214
New +$453K 0.04% 83

Other funds holding ADPT

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
AWM
Affinity Wealth Management Wilmington, Delaware $776M AUM 43.59% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EWM
Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Counterpoint Mutual Funds's ADPT Position: Q2 2026 in Review

Counterpoint Mutual Funds sold out of Adaptive Biotechnologies (ADPT) in Q2 2026, closing a stake of 307,268 shares — an estimated $4.26M sold.

Counterpoint Mutual Funds first reported a position in ADPT in Q3 2025 and held it in 2 quarters. The position peaked at $4.26M in Q1 2026. 44 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Counterpoint Mutual Funds reported no remaining Adaptive Biotechnologies position as of Q2 2026 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 307,268 Adaptive Biotechnologies shares in Q2 2026, an estimated $4.26M.
  • Counterpoint Mutual Funds first reported a position in Adaptive Biotechnologies in Q3 2025 and held it in 2 quarters.
  • Counterpoint Mutual Funds's Adaptive Biotechnologies position peaked at $4.26M in Q1 2026.
  • 44 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q2 2026, filed 20 Jul 2026.